Transverse Abdominal Block for Analgesia in Casarean Section

• Status: Completed
• Trial end date: 2014-06-01
• Target enrollment: 0
• Participant gender: Female

Summary

In this study, the investigators will compare the analgesic effect of bupivacaine and bupivacaine-dexmetomedine after elective cesarean delivery by performing an bilateral TAP block, on the patients for whom the operation will be performed under general anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Tanta University
• Treatments: Bupivacaine; Dexmedetomidine

Criteria

Inclusion Criteria:

1. We will study 60 ASA [American Society of Anesthesiologist] physical status I and ІІ patients undergoing elective cesarean delivery

2. Age between 21-40 years old.

Exclusion Criteria:

1. Refusal of participation in the study

2. Patients who have infection or tumor at the site of puncture for local anesthetic injection.

3. Patients who have coagulopathy, platelet abnormalities, and concurrent treatment with anticoagulant drugs.

4. Patients known to have allergy or sensitivity to dexmetomedine, and/or bupivacaine

5. Severe hepatic and/or renal insufficiency

6. Morbid obesity (body mass index (BMI) >35)

7. Psychological disease